Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bain Capital Specialty Finance (BCSF) Cash & Equivalents (2021 - 2025)

Bain Capital Specialty Finance has reported Cash & Equivalents over the past 5 years, most recently at $38.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $38.8 million for Q4 2025, down 24.72% from a year ago — trailing twelve months through Dec 2025 was $38.8 million (down 24.72% YoY), and the annual figure for FY2025 was $38.8 million, down 24.72%.
  • Cash & Equivalents for Q4 2025 was $38.8 million at Bain Capital Specialty Finance, down from $53.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BCSF hit a ceiling of $125.7 million in Q4 2022 and a floor of $10.2 million in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $51.6 million (2024), compared with a mean of $54.8 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 102.44% in 2024 and later tumbled 78.23% in 2025.
  • Bain Capital Specialty Finance's Cash & Equivalents stood at $87.4 million in 2021, then skyrocketed by 43.79% to $125.7 million in 2022, then crashed by 65.8% to $43.0 million in 2023, then rose by 19.93% to $51.6 million in 2024, then fell by 24.72% to $38.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $38.8 million (Q4 2025), $53.2 million (Q3 2025), and $27.8 million (Q2 2025) per Business Quant data.